Arno Therapeutics, Inc.
ARNI · OTC
9/30/2016 | 6/30/2016 | 3/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,849 | -$2,142 | -$3,709 | -$3,995 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $10 | $2 |
| Stock-Based Comp. | $1,025 | $1,013 | $908 | $615 |
| Change in WC | -$329 | $566 | -$764 | -$33 |
| Other Non-Cash | $2,011 | -$1,118 | $898 | $1,265 |
| Operating Cash Flow | -$1,140 | -$1,680 | -$2,655 | -$2,143 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | -$1 | $2,099 |
| Stock Issued | $2,178 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $150 | -$66 | $0 | -$13 |
| Financing Cash Flow | $2,327 | -$67 | $5,272 | $2,087 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1,187 | -$1,747 | $2,617 | -$56 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $937 | $2,684 | $67 | $123 |
| End Cash | $2,124 | $937 | $2,684 | $67 |
| Free Cash Flow | -$1,140 | -$1,680 | -$2,655 | -$2,143 |